We are live on ! Find out more
DSCI

Derma Sciences, Inc. Common Stock (DE)
DSCI

Delisted

DSCI was delisted on the 23rd of February, 2017.

Back to rankings

1 hedge funds and large institutions have $1.61M invested in Derma Sciences, Inc. Common Stock (DE) in 2017 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 47 closing their positions.

New
Increased
Maintained
Reduced
Closed

98% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 47

98% less funds holding

Funds holding: 52 → 1 (-51)

98% less capital invested

Capital invested by funds: $87.2M → $1.61M (-$85.6M)

Holders
1
Holders Change
-51
Holders Change %
-98.08%
% of All Funds
0.02%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
–
Closed
47
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
FPF
FNY Partners Fund
New York
+$1.54M

Top Sellers

Rank Fund Capital Flow
1
BBA
Baker Bros. Advisors
New York
-$19.5M
2
Franklin Resources
Franklin Resources
California
-$13.9M
3
BC
Broadfin Capital
New York
-$13.3M
4
Jennison Associates
Jennison Associates
New York
-$7.34M
5
GIM
Granahan Investment Management
Massachusetts
-$5.97M
Name Holding Trade Value Shares
Change 		Change in
Stake
Bank of New York Mellon
26
Bank of New York Mellon
New York
– -$97K -18,625 Closed
PAM
27
Panagora Asset Management
Massachusetts
– -$96K -18,405 Closed
Bank of America
28
Bank of America
North Carolina
– -$73K -13,943 Closed
BGIM
29
Brandywine Global Investment Management
Pennsylvania
– -$73K -13,910 Closed
AIM
30
Acrospire Investment Management
Illinois
– -$66K -12,633 Closed
Morgan Stanley
31
Morgan Stanley
New York
– -$64K -12,257 Closed
Commonwealth Equity Services
32
Commonwealth Equity Services
Massachusetts
– -$63K -12,100 Closed
PNC Financial Services Group
33
PNC Financial Services Group
Pennsylvania
– -$62K -12,000 Closed
State Street
34
State Street
Massachusetts
– -$62K -11,858 Closed
AIM
35
Alambic Investment Management
California
– -$59K -11,320 Closed
NFA
36
Nationwide Fund Advisors
Ohio
– -$36K -6,892 Closed
UBS Group
37
UBS Group
Switzerland
– -$34K -6,599 Closed
Russell Investments Group
38
Russell Investments Group
United Kingdom
– -$33K -6,352 Closed
VNA
39
Valley National Advisers
Pennsylvania
– -$26K -5,000 Closed
SCM
40
Segantii Capital Management
Hong Kong
– -$25K -4,900 Closed
Deutsche Bank
41
Deutsche Bank
Germany
– -$5K -1,104 Closed
PCM
42
Prelude Capital Management
New York
– -$5K -1,000 Closed
PMFA
43
Plante Moran Financial Advisors
Michigan
– -$3K -669 Closed
Wells Fargo
44
Wells Fargo
California
– -$3K -627 Closed
TRCT
45
Tower Research Capital (TRC)
New York
– -$3K -524 Closed
Simplex Trading
46
Simplex Trading
Illinois
– -$1K -278 Closed
1
2

DSCI Hedge Fund Activity: Q1 2017 in Review

1 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in Derma Sciences, Inc. Common Stock (DE) (DSCI) for Q1 2017, worth a combined $1.61M — down 98% from $87.2M a quarter earlier.

Sellers outnumbered buyers: 47 funds closed out of DSCI and 1 opened new positions — a net loss of 46 holders — while 0 trimmed existing stakes and 0 added.

The largest buyer was FNY Partners Fund, opening a new position worth an estimated $1.54M. The largest seller was Baker Bros. Advisors, exiting entirely with an estimated $19.5M sold.

  • 1 institutional investor held Derma Sciences, Inc. Common Stock (DE) (DSCI) as of Q1 2017, down from 52 in Q4 2016.
  • Funds reported $1.61M of Derma Sciences, Inc. Common Stock (DE) stock for Q1 2017, down 98% quarter-over-quarter.
  • 1 fund opened new Derma Sciences, Inc. Common Stock (DE) positions in Q1 2017 and 47 closed out, a net change of -46 holders.
  • The largest Derma Sciences, Inc. Common Stock (DE) buyer in Q1 2017 was FNY Partners Fund, an estimated $1.54M added.
  • The largest Derma Sciences, Inc. Common Stock (DE) seller in Q1 2017 was Baker Bros. Advisors, an estimated $19.5M sold.

Based on aggregated 13F filings for Q1 2017.